nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—melanoma	0.664	1	CbGaD
Risedronate—FDPS—hair follicle—melanoma	0.00794	0.149	CbGeAlD
Risedronate—PTGS2—leg—melanoma	0.00669	0.126	CbGeAlD
Risedronate—PTGS2—hindlimb—melanoma	0.00598	0.113	CbGeAlD
Risedronate—PTGS2—appendage—melanoma	0.00513	0.0965	CbGeAlD
Risedronate—PTGS2—skin epidermis—melanoma	0.00427	0.0803	CbGeAlD
Risedronate—FDPS—eye—melanoma	0.00396	0.0746	CbGeAlD
Risedronate—FDPS—skin of body—melanoma	0.00345	0.0649	CbGeAlD
Risedronate—FDPS—mammalian vulva—melanoma	0.00314	0.0592	CbGeAlD
Risedronate—PTGS2—endothelium—melanoma	0.0031	0.0583	CbGeAlD
Risedronate—PTGS2—blood vessel—melanoma	0.00285	0.0537	CbGeAlD
Risedronate—FDPS—head—melanoma	0.00225	0.0423	CbGeAlD
Risedronate—FDPS—lymph node—melanoma	0.00158	0.0297	CbGeAlD
Risedronate—PTGS2—skin of body—melanoma	0.00132	0.0249	CbGeAlD
Risedronate—Neoplasm—Carmustine—melanoma	0.00123	0.00583	CcSEcCtD
Risedronate—Dry eye—Temozolomide—melanoma	0.00121	0.00576	CcSEcCtD
Risedronate—Eye disorder—Vemurafenib—melanoma	0.0012	0.00572	CcSEcCtD
Risedronate—Cardiac disorder—Vemurafenib—melanoma	0.00119	0.00568	CcSEcCtD
Risedronate—Neoplasm—Temozolomide—melanoma	0.00118	0.00564	CcSEcCtD
Risedronate—Dermatitis atopic—Docetaxel—melanoma	0.00118	0.0056	CcSEcCtD
Risedronate—Angiopathy—Vemurafenib—melanoma	0.00117	0.00556	CcSEcCtD
Risedronate—Mediastinal disorder—Vemurafenib—melanoma	0.00116	0.00552	CcSEcCtD
Risedronate—Arthritis—Bleomycin—melanoma	0.00116	0.00552	CcSEcCtD
Risedronate—Malnutrition—Vemurafenib—melanoma	0.00112	0.00533	CcSEcCtD
Risedronate—Otitis media—Docetaxel—melanoma	0.00112	0.00532	CcSEcCtD
Risedronate—Back pain—Vemurafenib—melanoma	0.00108	0.00516	CcSEcCtD
Risedronate—Gastroenteritis—Temozolomide—melanoma	0.00107	0.0051	CcSEcCtD
Risedronate—Injury—Carmustine—melanoma	0.00107	0.00509	CcSEcCtD
Risedronate—Cough—Vemurafenib—melanoma	0.000978	0.00465	CcSEcCtD
Risedronate—Liver function test abnormal—Dactinomycin—melanoma	0.000971	0.00462	CcSEcCtD
Risedronate—Bone disorder—Docetaxel—melanoma	0.000965	0.00459	CcSEcCtD
Risedronate—Myalgia—Vemurafenib—melanoma	0.000954	0.00454	CcSEcCtD
Risedronate—Arthralgia—Vemurafenib—melanoma	0.000954	0.00454	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000947	0.00451	CcSEcCtD
Risedronate—Bone pain—Docetaxel—melanoma	0.000909	0.00433	CcSEcCtD
Risedronate—Infection—Vemurafenib—melanoma	0.000909	0.00432	CcSEcCtD
Risedronate—Liver function test abnormal—Carmustine—melanoma	0.000908	0.00432	CcSEcCtD
Risedronate—Inflammation—Docetaxel—melanoma	0.000898	0.00427	CcSEcCtD
Risedronate—Nervous system disorder—Vemurafenib—melanoma	0.000897	0.00427	CcSEcCtD
Risedronate—Skin disorder—Vemurafenib—melanoma	0.000888	0.00423	CcSEcCtD
Risedronate—Pneumonia—Bleomycin—melanoma	0.000874	0.00416	CcSEcCtD
Risedronate—Muscular weakness—Carmustine—melanoma	0.000868	0.00413	CcSEcCtD
Risedronate—PTGS2—head—melanoma	0.000862	0.0162	CbGeAlD
Risedronate—Breast disorder—Temozolomide—melanoma	0.000859	0.00409	CcSEcCtD
Risedronate—Influenza like illness—Docetaxel—melanoma	0.000846	0.00403	CcSEcCtD
Risedronate—Muscular weakness—Temozolomide—melanoma	0.000839	0.00399	CcSEcCtD
Risedronate—Colitis—Docetaxel—melanoma	0.000836	0.00398	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000833	0.00396	CcSEcCtD
Risedronate—Abdominal distension—Temozolomide—melanoma	0.000827	0.00394	CcSEcCtD
Risedronate—Pneumonia—Dactinomycin—melanoma	0.000815	0.00388	CcSEcCtD
Risedronate—Oesophagitis—Docetaxel—melanoma	0.000796	0.00379	CcSEcCtD
Risedronate—Bronchitis—Temozolomide—melanoma	0.00079	0.00376	CcSEcCtD
Risedronate—Gastrointestinal disorder—Vemurafenib—melanoma	0.00079	0.00376	CcSEcCtD
Risedronate—Fatigue—Vemurafenib—melanoma	0.000788	0.00375	CcSEcCtD
Risedronate—Neoplasm—Docetaxel—melanoma	0.000788	0.00375	CcSEcCtD
Risedronate—Haemoglobin—Bleomycin—melanoma	0.000784	0.00373	CcSEcCtD
Risedronate—Constipation—Vemurafenib—melanoma	0.000782	0.00372	CcSEcCtD
Risedronate—Haemorrhage—Bleomycin—melanoma	0.00078	0.00371	CcSEcCtD
Risedronate—Upper respiratory tract infection—Temozolomide—melanoma	0.000764	0.00363	CcSEcCtD
Risedronate—Pneumonia—Carmustine—melanoma	0.000763	0.00363	CcSEcCtD
Risedronate—Depression—Carmustine—melanoma	0.000756	0.0036	CcSEcCtD
Risedronate—Urinary tract infection—Carmustine—melanoma	0.000737	0.00351	CcSEcCtD
Risedronate—Pneumonia—Temozolomide—melanoma	0.000737	0.00351	CcSEcCtD
Risedronate—Infestation NOS—Temozolomide—melanoma	0.000733	0.00349	CcSEcCtD
Risedronate—Infestation—Temozolomide—melanoma	0.000733	0.00349	CcSEcCtD
Risedronate—Depression—Temozolomide—melanoma	0.000731	0.00348	CcSEcCtD
Risedronate—Body temperature increased—Vemurafenib—melanoma	0.000723	0.00344	CcSEcCtD
Risedronate—Pharyngitis—Dactinomycin—melanoma	0.000722	0.00343	CcSEcCtD
Risedronate—Urinary tract infection—Temozolomide—melanoma	0.000712	0.00339	CcSEcCtD
Risedronate—Hepatobiliary disease—Temozolomide—melanoma	0.000693	0.0033	CcSEcCtD
Risedronate—Sinusitis—Temozolomide—melanoma	0.000688	0.00327	CcSEcCtD
Risedronate—Haemoglobin—Carmustine—melanoma	0.000684	0.00326	CcSEcCtD
Risedronate—Haemorrhage—Carmustine—melanoma	0.000681	0.00324	CcSEcCtD
Risedronate—Hypersensitivity—Vemurafenib—melanoma	0.000674	0.00321	CcSEcCtD
Risedronate—Oedema peripheral—Carmustine—melanoma	0.000671	0.00319	CcSEcCtD
Risedronate—Connective tissue disorder—Carmustine—melanoma	0.000669	0.00318	CcSEcCtD
Risedronate—Haemoglobin—Temozolomide—melanoma	0.000661	0.00315	CcSEcCtD
Risedronate—Haemorrhage—Temozolomide—melanoma	0.000658	0.00313	CcSEcCtD
Risedronate—Asthenia—Vemurafenib—melanoma	0.000656	0.00312	CcSEcCtD
Risedronate—Pharyngitis—Temozolomide—melanoma	0.000653	0.00311	CcSEcCtD
Risedronate—Urinary tract disorder—Temozolomide—melanoma	0.00065	0.00309	CcSEcCtD
Risedronate—Oedema peripheral—Temozolomide—melanoma	0.000648	0.00308	CcSEcCtD
Risedronate—Pruritus—Vemurafenib—melanoma	0.000647	0.00308	CcSEcCtD
Risedronate—Connective tissue disorder—Temozolomide—melanoma	0.000646	0.00308	CcSEcCtD
Risedronate—Urethral disorder—Temozolomide—melanoma	0.000645	0.00307	CcSEcCtD
Risedronate—Eye disorder—Carmustine—melanoma	0.000636	0.00303	CcSEcCtD
Risedronate—Pain in extremity—Docetaxel—melanoma	0.000632	0.00301	CcSEcCtD
Risedronate—Anaemia—Bleomycin—melanoma	0.000627	0.00299	CcSEcCtD
Risedronate—Diarrhoea—Vemurafenib—melanoma	0.000626	0.00298	CcSEcCtD
Risedronate—Eye disorder—Temozolomide—melanoma	0.000615	0.00293	CcSEcCtD
Risedronate—Tinnitus—Temozolomide—melanoma	0.000613	0.00292	CcSEcCtD
Risedronate—Cardiac disorder—Temozolomide—melanoma	0.000611	0.0029	CcSEcCtD
Risedronate—Arrhythmia—Carmustine—melanoma	0.000608	0.00289	CcSEcCtD
Risedronate—Dizziness—Vemurafenib—melanoma	0.000605	0.00288	CcSEcCtD
Risedronate—PTGS2—lymph node—melanoma	0.000604	0.0114	CbGeAlD
Risedronate—Angiopathy—Temozolomide—melanoma	0.000597	0.00284	CcSEcCtD
Risedronate—Mental disorder—Carmustine—melanoma	0.000596	0.00284	CcSEcCtD
Risedronate—Immune system disorder—Temozolomide—melanoma	0.000594	0.00283	CcSEcCtD
Risedronate—Mediastinal disorder—Temozolomide—melanoma	0.000593	0.00282	CcSEcCtD
Risedronate—Malnutrition—Carmustine—melanoma	0.000593	0.00282	CcSEcCtD
Risedronate—Cough—Bleomycin—melanoma	0.000592	0.00282	CcSEcCtD
Risedronate—Anaemia—Dactinomycin—melanoma	0.000585	0.00278	CcSEcCtD
Risedronate—Liver function test abnormal—Docetaxel—melanoma	0.000584	0.00278	CcSEcCtD
Risedronate—Vomiting—Vemurafenib—melanoma	0.000581	0.00277	CcSEcCtD
Risedronate—Myalgia—Bleomycin—melanoma	0.000578	0.00275	CcSEcCtD
Risedronate—Chest pain—Bleomycin—melanoma	0.000578	0.00275	CcSEcCtD
Risedronate—Abdominal pain upper—Docetaxel—melanoma	0.000578	0.00275	CcSEcCtD
Risedronate—Rash—Vemurafenib—melanoma	0.000577	0.00274	CcSEcCtD
Risedronate—Mental disorder—Temozolomide—melanoma	0.000576	0.00274	CcSEcCtD
Risedronate—Dermatitis—Vemurafenib—melanoma	0.000576	0.00274	CcSEcCtD
Risedronate—Back pain—Carmustine—melanoma	0.000573	0.00273	CcSEcCtD
Risedronate—Headache—Vemurafenib—melanoma	0.000573	0.00273	CcSEcCtD
Risedronate—Malnutrition—Temozolomide—melanoma	0.000573	0.00272	CcSEcCtD
Risedronate—Breast disorder—Docetaxel—melanoma	0.000571	0.00272	CcSEcCtD
Risedronate—Nasopharyngitis—Docetaxel—melanoma	0.000565	0.00269	CcSEcCtD
Risedronate—Back pain—Temozolomide—melanoma	0.000554	0.00264	CcSEcCtD
Risedronate—Infection—Bleomycin—melanoma	0.00055	0.00262	CcSEcCtD
Risedronate—Anaemia—Carmustine—melanoma	0.000548	0.00261	CcSEcCtD
Risedronate—Nausea—Vemurafenib—melanoma	0.000543	0.00258	CcSEcCtD
Risedronate—Myalgia—Dactinomycin—melanoma	0.000539	0.00256	CcSEcCtD
Risedronate—Angina pectoris—Docetaxel—melanoma	0.000532	0.00253	CcSEcCtD
Risedronate—Anaemia—Temozolomide—melanoma	0.000529	0.00252	CcSEcCtD
Risedronate—Angioedema—Temozolomide—melanoma	0.000523	0.00249	CcSEcCtD
Risedronate—Vertigo—Temozolomide—melanoma	0.000515	0.00245	CcSEcCtD
Risedronate—Infection—Dactinomycin—melanoma	0.000513	0.00244	CcSEcCtD
Risedronate—Hypertension—Carmustine—melanoma	0.000512	0.00243	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000505	0.0024	CcSEcCtD
Risedronate—Chest pain—Carmustine—melanoma	0.000505	0.0024	CcSEcCtD
Risedronate—Myalgia—Carmustine—melanoma	0.000505	0.0024	CcSEcCtD
Risedronate—Anxiety—Carmustine—melanoma	0.000503	0.00239	CcSEcCtD
Risedronate—Cough—Temozolomide—melanoma	0.0005	0.00238	CcSEcCtD
Risedronate—Paraesthesia—Bleomycin—melanoma	0.000498	0.00237	CcSEcCtD
Risedronate—Hypertension—Temozolomide—melanoma	0.000494	0.00235	CcSEcCtD
Risedronate—Dyspnoea—Bleomycin—melanoma	0.000494	0.00235	CcSEcCtD
Risedronate—Pneumonia—Docetaxel—melanoma	0.00049	0.00233	CcSEcCtD
Risedronate—Myalgia—Temozolomide—melanoma	0.000488	0.00232	CcSEcCtD
Risedronate—Arthralgia—Temozolomide—melanoma	0.000488	0.00232	CcSEcCtD
Risedronate—Infestation NOS—Docetaxel—melanoma	0.000487	0.00232	CcSEcCtD
Risedronate—Infestation—Docetaxel—melanoma	0.000487	0.00232	CcSEcCtD
Risedronate—Anxiety—Temozolomide—melanoma	0.000486	0.00231	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000484	0.0023	CcSEcCtD
Risedronate—Infection—Carmustine—melanoma	0.00048	0.00229	CcSEcCtD
Risedronate—Dry mouth—Temozolomide—melanoma	0.000477	0.00227	CcSEcCtD
Risedronate—Pain—Bleomycin—melanoma	0.000474	0.00225	CcSEcCtD
Risedronate—Conjunctivitis—Docetaxel—melanoma	0.000474	0.00225	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000471	0.00224	CcSEcCtD
Risedronate—Infection—Temozolomide—melanoma	0.000464	0.00221	CcSEcCtD
Risedronate—Hepatobiliary disease—Docetaxel—melanoma	0.000461	0.00219	CcSEcCtD
Risedronate—Nervous system disorder—Temozolomide—melanoma	0.000458	0.00218	CcSEcCtD
Risedronate—Skin disorder—Temozolomide—melanoma	0.000454	0.00216	CcSEcCtD
Risedronate—Fatigue—Dactinomycin—melanoma	0.000446	0.00212	CcSEcCtD
Risedronate—Pain—Dactinomycin—melanoma	0.000442	0.0021	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Carmustine—melanoma	0.000441	0.0021	CcSEcCtD
Risedronate—Urticaria—Bleomycin—melanoma	0.00044	0.00209	CcSEcCtD
Risedronate—Haemoglobin—Docetaxel—melanoma	0.00044	0.00209	CcSEcCtD
Risedronate—Rhinitis—Docetaxel—melanoma	0.000439	0.00209	CcSEcCtD
Risedronate—Body temperature increased—Bleomycin—melanoma	0.000438	0.00208	CcSEcCtD
Risedronate—Haemorrhage—Docetaxel—melanoma	0.000437	0.00208	CcSEcCtD
Risedronate—Insomnia—Carmustine—melanoma	0.000437	0.00208	CcSEcCtD
Risedronate—Paraesthesia—Carmustine—melanoma	0.000434	0.00207	CcSEcCtD
Risedronate—Pharyngitis—Docetaxel—melanoma	0.000434	0.00207	CcSEcCtD
Risedronate—Urinary tract disorder—Docetaxel—melanoma	0.000432	0.00206	CcSEcCtD
Risedronate—Dyspnoea—Carmustine—melanoma	0.000431	0.00205	CcSEcCtD
Risedronate—Oedema peripheral—Docetaxel—melanoma	0.000431	0.00205	CcSEcCtD
Risedronate—Connective tissue disorder—Docetaxel—melanoma	0.00043	0.00205	CcSEcCtD
Risedronate—Urethral disorder—Docetaxel—melanoma	0.000429	0.00204	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000426	0.00203	CcSEcCtD
Risedronate—Insomnia—Temozolomide—melanoma	0.000423	0.00201	CcSEcCtD
Risedronate—Gastrointestinal pain—Dactinomycin—melanoma	0.000423	0.00201	CcSEcCtD
Risedronate—Paraesthesia—Temozolomide—melanoma	0.00042	0.002	CcSEcCtD
Risedronate—Gastrointestinal disorder—Carmustine—melanoma	0.000418	0.00199	CcSEcCtD
Risedronate—Dyspnoea—Temozolomide—melanoma	0.000417	0.00198	CcSEcCtD
Risedronate—Constipation—Carmustine—melanoma	0.000414	0.00197	CcSEcCtD
Risedronate—Pain—Carmustine—melanoma	0.000414	0.00197	CcSEcCtD
Risedronate—Dyspepsia—Temozolomide—melanoma	0.000411	0.00196	CcSEcCtD
Risedronate—Eye disorder—Docetaxel—melanoma	0.000409	0.00195	CcSEcCtD
Risedronate—Body temperature increased—Dactinomycin—melanoma	0.000408	0.00194	CcSEcCtD
Risedronate—Abdominal pain—Dactinomycin—melanoma	0.000408	0.00194	CcSEcCtD
Risedronate—Hypersensitivity—Bleomycin—melanoma	0.000408	0.00194	CcSEcCtD
Risedronate—Cardiac disorder—Docetaxel—melanoma	0.000406	0.00193	CcSEcCtD
Risedronate—Gastrointestinal disorder—Temozolomide—melanoma	0.000404	0.00192	CcSEcCtD
Risedronate—Fatigue—Temozolomide—melanoma	0.000403	0.00192	CcSEcCtD
Risedronate—Pain—Temozolomide—melanoma	0.0004	0.0019	CcSEcCtD
Risedronate—Constipation—Temozolomide—melanoma	0.0004	0.0019	CcSEcCtD
Risedronate—Asthenia—Bleomycin—melanoma	0.000398	0.00189	CcSEcCtD
Risedronate—Angiopathy—Docetaxel—melanoma	0.000397	0.00189	CcSEcCtD
Risedronate—Gastrointestinal pain—Carmustine—melanoma	0.000395	0.00188	CcSEcCtD
Risedronate—Immune system disorder—Docetaxel—melanoma	0.000395	0.00188	CcSEcCtD
Risedronate—Mediastinal disorder—Docetaxel—melanoma	0.000394	0.00188	CcSEcCtD
Risedronate—Pruritus—Bleomycin—melanoma	0.000392	0.00187	CcSEcCtD
Risedronate—Arrhythmia—Docetaxel—melanoma	0.000391	0.00186	CcSEcCtD
Risedronate—Mental disorder—Docetaxel—melanoma	0.000383	0.00182	CcSEcCtD
Risedronate—Abdominal pain—Carmustine—melanoma	0.000382	0.00182	CcSEcCtD
Risedronate—Body temperature increased—Carmustine—melanoma	0.000382	0.00182	CcSEcCtD
Risedronate—Gastrointestinal pain—Temozolomide—melanoma	0.000382	0.00182	CcSEcCtD
Risedronate—Malnutrition—Docetaxel—melanoma	0.000381	0.00181	CcSEcCtD
Risedronate—Hypersensitivity—Dactinomycin—melanoma	0.000381	0.00181	CcSEcCtD
Risedronate—Urticaria—Temozolomide—melanoma	0.000371	0.00177	CcSEcCtD
Risedronate—Asthenia—Dactinomycin—melanoma	0.000371	0.00176	CcSEcCtD
Risedronate—Body temperature increased—Temozolomide—melanoma	0.000369	0.00176	CcSEcCtD
Risedronate—Abdominal pain—Temozolomide—melanoma	0.000369	0.00176	CcSEcCtD
Risedronate—Back pain—Docetaxel—melanoma	0.000368	0.00175	CcSEcCtD
Risedronate—Muscle spasms—Docetaxel—melanoma	0.000366	0.00174	CcSEcCtD
Risedronate—Hypersensitivity—Carmustine—melanoma	0.000356	0.0017	CcSEcCtD
Risedronate—Diarrhoea—Dactinomycin—melanoma	0.000354	0.00168	CcSEcCtD
Risedronate—Vomiting—Bleomycin—melanoma	0.000352	0.00168	CcSEcCtD
Risedronate—Anaemia—Docetaxel—melanoma	0.000352	0.00167	CcSEcCtD
Risedronate—Rash—Bleomycin—melanoma	0.000349	0.00166	CcSEcCtD
Risedronate—Dermatitis—Bleomycin—melanoma	0.000349	0.00166	CcSEcCtD
Risedronate—Asthenia—Carmustine—melanoma	0.000347	0.00165	CcSEcCtD
Risedronate—Hypersensitivity—Temozolomide—melanoma	0.000344	0.00164	CcSEcCtD
Risedronate—Syncope—Docetaxel—melanoma	0.000342	0.00162	CcSEcCtD
Risedronate—Asthenia—Temozolomide—melanoma	0.000335	0.0016	CcSEcCtD
Risedronate—Loss of consciousness—Docetaxel—melanoma	0.000335	0.00159	CcSEcCtD
Risedronate—Cough—Docetaxel—melanoma	0.000332	0.00158	CcSEcCtD
Risedronate—Diarrhoea—Carmustine—melanoma	0.000331	0.00157	CcSEcCtD
Risedronate—Pruritus—Temozolomide—melanoma	0.000331	0.00157	CcSEcCtD
Risedronate—Nausea—Bleomycin—melanoma	0.000329	0.00157	CcSEcCtD
Risedronate—Hypertension—Docetaxel—melanoma	0.000329	0.00156	CcSEcCtD
Risedronate—Vomiting—Dactinomycin—melanoma	0.000329	0.00156	CcSEcCtD
Risedronate—Rash—Dactinomycin—melanoma	0.000326	0.00155	CcSEcCtD
Risedronate—Arthralgia—Docetaxel—melanoma	0.000324	0.00154	CcSEcCtD
Risedronate—Myalgia—Docetaxel—melanoma	0.000324	0.00154	CcSEcCtD
Risedronate—Chest pain—Docetaxel—melanoma	0.000324	0.00154	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000322	0.00153	CcSEcCtD
Risedronate—Dizziness—Carmustine—melanoma	0.00032	0.00152	CcSEcCtD
Risedronate—Diarrhoea—Temozolomide—melanoma	0.00032	0.00152	CcSEcCtD
Risedronate—Dry mouth—Docetaxel—melanoma	0.000317	0.00151	CcSEcCtD
Risedronate—Dizziness—Temozolomide—melanoma	0.000309	0.00147	CcSEcCtD
Risedronate—Infection—Docetaxel—melanoma	0.000309	0.00147	CcSEcCtD
Risedronate—Vomiting—Carmustine—melanoma	0.000308	0.00146	CcSEcCtD
Risedronate—Nausea—Dactinomycin—melanoma	0.000307	0.00146	CcSEcCtD
Risedronate—Shock—Docetaxel—melanoma	0.000306	0.00145	CcSEcCtD
Risedronate—Rash—Carmustine—melanoma	0.000305	0.00145	CcSEcCtD
Risedronate—Nervous system disorder—Docetaxel—melanoma	0.000305	0.00145	CcSEcCtD
Risedronate—Dermatitis—Carmustine—melanoma	0.000305	0.00145	CcSEcCtD
Risedronate—Headache—Carmustine—melanoma	0.000303	0.00144	CcSEcCtD
Risedronate—Skin disorder—Docetaxel—melanoma	0.000302	0.00144	CcSEcCtD
Risedronate—Vomiting—Temozolomide—melanoma	0.000297	0.00141	CcSEcCtD
Risedronate—Rash—Temozolomide—melanoma	0.000295	0.0014	CcSEcCtD
Risedronate—Dermatitis—Temozolomide—melanoma	0.000294	0.0014	CcSEcCtD
Risedronate—Headache—Temozolomide—melanoma	0.000293	0.00139	CcSEcCtD
Risedronate—Nausea—Carmustine—melanoma	0.000287	0.00137	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000283	0.00135	CcSEcCtD
Risedronate—Insomnia—Docetaxel—melanoma	0.000281	0.00134	CcSEcCtD
Risedronate—Paraesthesia—Docetaxel—melanoma	0.000279	0.00133	CcSEcCtD
Risedronate—Nausea—Temozolomide—melanoma	0.000278	0.00132	CcSEcCtD
Risedronate—Dyspnoea—Docetaxel—melanoma	0.000277	0.00132	CcSEcCtD
Risedronate—Dyspepsia—Docetaxel—melanoma	0.000274	0.0013	CcSEcCtD
Risedronate—Gastrointestinal disorder—Docetaxel—melanoma	0.000268	0.00128	CcSEcCtD
Risedronate—Fatigue—Docetaxel—melanoma	0.000268	0.00127	CcSEcCtD
Risedronate—Pain—Docetaxel—melanoma	0.000266	0.00126	CcSEcCtD
Risedronate—Constipation—Docetaxel—melanoma	0.000266	0.00126	CcSEcCtD
Risedronate—Gastrointestinal pain—Docetaxel—melanoma	0.000254	0.00121	CcSEcCtD
Risedronate—Body temperature increased—Docetaxel—melanoma	0.000246	0.00117	CcSEcCtD
Risedronate—Abdominal pain—Docetaxel—melanoma	0.000246	0.00117	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.000236	0.00324	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HPSE—melanoma	0.000234	0.00322	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—IL6—melanoma	0.000234	0.00321	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CUBN—melanoma	0.00023	0.00316	CbGpPWpGaD
Risedronate—Hypersensitivity—Docetaxel—melanoma	0.000229	0.00109	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	0.000229	0.00314	CbGpPWpGaD
Risedronate—Asthenia—Docetaxel—melanoma	0.000223	0.00106	CcSEcCtD
Risedronate—FDPS—Metabolism—SDHD—melanoma	0.000222	0.00305	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CSPG4—melanoma	0.000222	0.00305	CbGpPWpGaD
Risedronate—FDPS—Metabolism—BSG—melanoma	0.000222	0.00305	CbGpPWpGaD
Risedronate—Pruritus—Docetaxel—melanoma	0.00022	0.00105	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—melanoma	0.000217	0.00298	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—APEX1—melanoma	0.000215	0.00296	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GPAM—melanoma	0.000215	0.00295	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NGFR—melanoma	0.000213	0.00292	CbGpPWpGaD
Risedronate—Diarrhoea—Docetaxel—melanoma	0.000213	0.00101	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—melanoma	0.000207	0.00283	CbGpPWpGaD
Risedronate—Dizziness—Docetaxel—melanoma	0.000206	0.000978	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	0.0002	0.00275	CbGpPWpGaD
Risedronate—Vomiting—Docetaxel—melanoma	0.000198	0.00094	CcSEcCtD
Risedronate—Rash—Docetaxel—melanoma	0.000196	0.000932	CcSEcCtD
Risedronate—Dermatitis—Docetaxel—melanoma	0.000196	0.000932	CcSEcCtD
Risedronate—Headache—Docetaxel—melanoma	0.000195	0.000926	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—melanoma	0.000192	0.00264	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	0.000185	0.00254	CbGpPWpGaD
Risedronate—Nausea—Docetaxel—melanoma	0.000185	0.000878	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—melanoma	0.000184	0.00252	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	0.000184	0.00252	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—melanoma	0.000184	0.00252	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PLA2G6—melanoma	0.000183	0.00251	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ICAM1—melanoma	0.000173	0.00237	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—KIT—melanoma	0.000172	0.00236	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL4—melanoma	0.000172	0.00236	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—E2F1—melanoma	0.000171	0.00235	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—PRKCA—melanoma	0.000168	0.0023	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	0.000167	0.00229	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—melanoma	0.000165	0.00226	CbGpPWpGaD
Risedronate—FDPS—Metabolism—VCAN—melanoma	0.000164	0.00226	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—melanoma	0.000157	0.00215	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000156	0.00214	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—RAC1—melanoma	0.000155	0.00213	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—MYC—melanoma	0.000153	0.00211	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00015	0.00206	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	0.00015	0.00206	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—melanoma	0.00015	0.00206	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000148	0.00204	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CDK2—melanoma	0.000147	0.00202	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALB—melanoma	0.000144	0.00198	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—melanoma	0.000143	0.00196	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TLR4—melanoma	0.000142	0.00196	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—melanoma	0.000142	0.00195	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN2A—melanoma	0.00014	0.00192	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CDK4—melanoma	0.000139	0.00191	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP17A1—melanoma	0.000139	0.0019	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—BCL2—melanoma	0.000138	0.00189	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000137	0.00188	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—ICAM1—melanoma	0.000137	0.00187	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NOS2—melanoma	0.000135	0.00186	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000135	0.00185	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—melanoma	0.000134	0.00183	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CD4—melanoma	0.000132	0.00181	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IFNG—melanoma	0.000131	0.0018	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GNA11—melanoma	0.000131	0.0018	CbGpPWpGaD
Risedronate—PTGS2—Disease—MYO7A—melanoma	0.00013	0.00179	CbGpPWpGaD
Risedronate—FDPS—Metabolism—FASN—melanoma	0.000128	0.00176	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000127	0.00174	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SLC5A5—melanoma	0.000126	0.00173	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN1B—melanoma	0.000124	0.0017	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000124	0.0017	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000124	0.0017	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CD44—melanoma	0.000122	0.00167	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GNAQ—melanoma	0.000122	0.00167	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—RB1—melanoma	0.000121	0.00166	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—melanoma	0.00012	0.00165	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000119	0.00164	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000119	0.00163	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000118	0.00162	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CCND1—melanoma	0.000118	0.00162	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP1B1—melanoma	0.000117	0.0016	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000116	0.0016	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000116	0.00159	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000115	0.00158	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CDKN1A—melanoma	0.000114	0.00157	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000114	0.00156	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000112	0.00153	CbGpPWpGaD
Risedronate—PTGS2—Disease—HS3ST5—melanoma	0.000111	0.00152	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.00011	0.00151	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—NFKB1—melanoma	0.000109	0.0015	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ACER3—melanoma	0.000109	0.0015	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000108	0.00148	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000106	0.00145	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IFNG—melanoma	0.000104	0.00143	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000103	0.00141	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—NRAS—melanoma	0.000102	0.0014	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.0001	0.00138	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—UGT2B10—melanoma	9.97e-05	0.00137	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	9.84e-05	0.00135	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CXCL8—melanoma	9.66e-05	0.00133	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCB1—melanoma	9.61e-05	0.00132	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—melanoma	9.52e-05	0.00131	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	9.48e-05	0.0013	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—MYC—melanoma	9.48e-05	0.0013	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CDKN1B—melanoma	9.44e-05	0.0013	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HS3ST5—melanoma	9.27e-05	0.00127	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CASP3—melanoma	9.25e-05	0.00127	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL2—melanoma	9.23e-05	0.00127	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCND1—melanoma	9e-05	0.00124	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—APC—melanoma	8.93e-05	0.00123	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PRKCA—melanoma	8.85e-05	0.00121	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—melanoma	8.82e-05	0.00121	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ERCC2—melanoma	8.78e-05	0.0012	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—KRAS—melanoma	8.76e-05	0.0012	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MMP9—melanoma	8.74e-05	0.0012	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—melanoma	8.5e-05	0.00117	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	8.31e-05	0.00114	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	8.17e-05	0.00112	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	7.9e-05	0.00108	CbGpPWpGaD
Risedronate—PTGS2—Disease—TRRAP—melanoma	7.89e-05	0.00108	CbGpPWpGaD
Risedronate—PTGS2—Disease—CUL3—melanoma	7.89e-05	0.00108	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKR1B10—melanoma	7.67e-05	0.00105	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	7.51e-05	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	7.46e-05	0.00102	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—HRAS—melanoma	7.44e-05	0.00102	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MAPK3—melanoma	7.42e-05	0.00102	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.27e-05	0.000998	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MYC—melanoma	7.22e-05	0.000991	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	7.13e-05	0.000979	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MAPK1—melanoma	7.06e-05	0.00097	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—EGFR—melanoma	7.06e-05	0.000969	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	7.03e-05	0.000965	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLCB4—melanoma	7.02e-05	0.000964	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	6.93e-05	0.000951	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CG—melanoma	6.93e-05	0.000951	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	6.89e-05	0.000946	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—melanoma	6.86e-05	0.000942	CbGpPWpGaD
Risedronate—PTGS2—Disease—LUM—melanoma	6.84e-05	0.000939	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TNF—melanoma	6.73e-05	0.000923	CbGpPWpGaD
Risedronate—PTGS2—Disease—HPSE—melanoma	6.7e-05	0.00092	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARG—melanoma	6.69e-05	0.000918	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC6A11—melanoma	6.6e-05	0.000906	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIP4K2A—melanoma	6.6e-05	0.000906	CbGpPWpGaD
Risedronate—PTGS2—Disease—CUBN—melanoma	6.58e-05	0.000903	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTAP—melanoma	6.42e-05	0.000882	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	6.42e-05	0.000881	CbGpPWpGaD
Risedronate—PTGS2—Disease—CSPG4—melanoma	6.36e-05	0.000872	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	6.29e-05	0.000863	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.28e-05	0.000862	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS3—melanoma	6.25e-05	0.000858	CbGpPWpGaD
Risedronate—PTGS2—Disease—SKI—melanoma	6.16e-05	0.000845	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	6.12e-05	0.00084	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CD—melanoma	6.09e-05	0.000836	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	6.06e-05	0.000832	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALB—melanoma	6.01e-05	0.000826	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TP53—melanoma	5.93e-05	0.000814	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.92e-05	0.000813	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.91e-05	0.000811	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	5.88e-05	0.000807	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PHGDH—melanoma	5.73e-05	0.000786	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LUM—melanoma	5.73e-05	0.000786	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HPSE—melanoma	5.62e-05	0.000771	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CUBN—melanoma	5.51e-05	0.000757	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—melanoma	5.43e-05	0.000745	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.34e-05	0.000733	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SDHD—melanoma	5.32e-05	0.000731	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—BSG—melanoma	5.32e-05	0.000731	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CSPG4—melanoma	5.32e-05	0.000731	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CB—melanoma	5.31e-05	0.000729	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—melanoma	5.26e-05	0.000722	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPAM—melanoma	5.16e-05	0.000708	CbGpPWpGaD
Risedronate—PTGS2—Disease—HDAC6—melanoma	5.08e-05	0.000698	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.05e-05	0.000693	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.91e-05	0.000674	CbGpPWpGaD
Risedronate—PTGS2—Disease—NPPA—melanoma	4.82e-05	0.000661	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.8e-05	0.00066	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.8e-05	0.000659	CbGpPWpGaD
Risedronate—PTGS2—Disease—VCAN—melanoma	4.7e-05	0.000645	CbGpPWpGaD
Risedronate—PTGS2—Disease—WNT5A—melanoma	4.67e-05	0.00064	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTEN—melanoma	4.59e-05	0.00063	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.57e-05	0.000628	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.54e-05	0.000623	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLA2G6—melanoma	4.38e-05	0.000602	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.17e-05	0.000572	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.03e-05	0.000554	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—VCAN—melanoma	3.94e-05	0.00054	CbGpPWpGaD
Risedronate—PTGS2—Disease—GAB2—melanoma	3.75e-05	0.000514	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.73e-05	0.000512	CbGpPWpGaD
Risedronate—PTGS2—Disease—FASN—melanoma	3.67e-05	0.000503	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.6e-05	0.000494	CbGpPWpGaD
Risedronate—PTGS2—Disease—CXCR4—melanoma	3.52e-05	0.000483	CbGpPWpGaD
Risedronate—PTGS2—Disease—HDAC2—melanoma	3.52e-05	0.000483	CbGpPWpGaD
Risedronate—PTGS2—Disease—FOXO4—melanoma	3.52e-05	0.000483	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD44—melanoma	3.48e-05	0.000478	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.41e-05	0.000468	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP17A1—melanoma	3.32e-05	0.000456	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.28e-05	0.00045	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CA—melanoma	3.24e-05	0.000444	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.23e-05	0.000444	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT3—melanoma	3.21e-05	0.000441	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GNA11—melanoma	3.14e-05	0.000431	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—FASN—melanoma	3.07e-05	0.000421	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC5A5—melanoma	3.02e-05	0.000415	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GNAQ—melanoma	2.92e-05	0.0004	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CD44—melanoma	2.92e-05	0.0004	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.86e-05	0.000392	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERBB4—melanoma	2.84e-05	0.00039	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN2B—melanoma	2.81e-05	0.000386	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP1B1—melanoma	2.8e-05	0.000384	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD86—melanoma	2.72e-05	0.000374	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—melanoma	2.64e-05	0.000363	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF1—melanoma	2.64e-05	0.000362	CbGpPWpGaD
Risedronate—PTGS2—Disease—PDGFRA—melanoma	2.56e-05	0.000351	CbGpPWpGaD
Risedronate—PTGS2—Disease—PRKCA—melanoma	2.53e-05	0.000347	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERCC2—melanoma	2.51e-05	0.000344	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAP2K2—melanoma	2.47e-05	0.00034	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.47e-05	0.000339	CbGpPWpGaD
Risedronate—PTGS2—Disease—TERT—melanoma	2.35e-05	0.000323	CbGpPWpGaD
Risedronate—PTGS2—Disease—HLA-A—melanoma	2.35e-05	0.000323	CbGpPWpGaD
Risedronate—PTGS2—Disease—RAC1—melanoma	2.35e-05	0.000322	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCB1—melanoma	2.3e-05	0.000316	CbGpPWpGaD
Risedronate—PTGS2—Disease—HIF1A—melanoma	2.25e-05	0.000309	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PRKCA—melanoma	2.12e-05	0.000291	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ERCC2—melanoma	2.1e-05	0.000289	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS2—melanoma	2.05e-05	0.000281	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOTCH1—melanoma	2.03e-05	0.000278	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD80—melanoma	1.99e-05	0.000273	CbGpPWpGaD
Risedronate—PTGS2—Disease—APC—melanoma	1.98e-05	0.000272	CbGpPWpGaD
Risedronate—PTGS2—Disease—KIT—melanoma	1.98e-05	0.000272	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGF—melanoma	1.96e-05	0.000269	CbGpPWpGaD
Risedronate—PTGS2—Disease—BRAF—melanoma	1.86e-05	0.000256	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAP2K1—melanoma	1.75e-05	0.000241	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CD—melanoma	1.74e-05	0.000239	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.74e-05	0.000239	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF2—melanoma	1.67e-05	0.000229	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CG—melanoma	1.66e-05	0.000228	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARG—melanoma	1.6e-05	0.00022	CbGpPWpGaD
Risedronate—PTGS2—Disease—MDM2—melanoma	1.56e-05	0.000214	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERBB2—melanoma	1.54e-05	0.000211	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CB—melanoma	1.52e-05	0.000208	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD4—melanoma	1.52e-05	0.000208	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CD—melanoma	1.46e-05	0.0002	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—melanoma	1.44e-05	0.000198	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1B—melanoma	1.43e-05	0.000196	CbGpPWpGaD
Risedronate—PTGS2—Disease—CTNNB1—melanoma	1.35e-05	0.000185	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1A—melanoma	1.32e-05	0.000181	CbGpPWpGaD
Risedronate—PTGS2—Disease—PTEN—melanoma	1.31e-05	0.00018	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CB—melanoma	1.27e-05	0.000175	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT3—melanoma	1.17e-05	0.000161	CbGpPWpGaD
Risedronate—PTGS2—Disease—NRAS—melanoma	1.17e-05	0.000161	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAPK3—melanoma	1.12e-05	0.000154	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTEN—melanoma	1.1e-05	0.000151	CbGpPWpGaD
Risedronate—PTGS2—Disease—MYC—melanoma	1.09e-05	0.00015	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAPK1—melanoma	1.07e-05	0.000146	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGFR—melanoma	1.07e-05	0.000146	CbGpPWpGaD
Risedronate—PTGS2—Disease—KRAS—melanoma	1.01e-05	0.000138	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CA—melanoma	9.26e-06	0.000127	CbGpPWpGaD
Risedronate—PTGS2—Disease—HRAS—melanoma	8.57e-06	0.000118	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—melanoma	8.2e-06	0.000113	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CA—melanoma	7.75e-06	0.000106	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—melanoma	7.56e-06	0.000104	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—melanoma	6.33e-06	8.69e-05	CbGpPWpGaD
